Options Traders Just Cashed In on CREE Stock's Incredible Rally

Our bullish recommendation on CREE shares was perfectly timed to capture the stock's bounce

by Lillian Currens

Published on Apr 4, 2019 at 4:12 PM

Subscribers to Schaeffer's Weekly Options Countdown options recommendation service just doubled their money in only a few trading days with the Cree Inc (NASDAQ:CREE) weekly 4/5 55.50-strike call. Here's a quick look at why we expected a big upside move from the semiconductor concern this week, and how the profitable options trade unfolded.

At the time of our initial recommendation this past Sunday, March 31, Cree shares were up an impressive 34% in 2019, despite a recent pullback from the highs they achieved after selling a business unit. Plus, support from the $55 level helped cushion this period of consolidation as the stock worked off overbought readings.

The $55 level was where CREE was trading before its latest spike. We suspected that this area, which is also home to its 20-day moving average, could serve as a springboard in the short term. A short squeeze was a potential catalyst higher, too, as short interest accounted for 10 times the security's average daily trading volume.

Short-term options on Cree were attractively priced when we recommended the trade. The security's Schaeffer's Volatility Index (SVI) of 32% registered in the 7th percentile of its 12-month range.

In the wake of our recommendation to subscribers on Sunday night, CREE stock started the week strong with a 4.3% rally by Monday's close. The bullish momentum continued on Tuesday with a 1.2% advance, and CREE's opening gap higher on Wednesday was sufficient to push our weekly option to its target profit of 100% -- just barely two days after subscribers entered the trade.  

CREE Apr 4

From Schaeffer's Pro Traders
Trade Weekly Options Like a Pro

Direct from our Schaeffer's traders, your FREE guide to profiting with weeklies!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.
Drug Stock Doubles on Trial Update
ETON is another name making a big move in the healthcare space
Wall Street Dishes Out "Sell" Ratings on Healthcare Stocks
Multiple bear notes have hit the healthcare sector today
Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.